Regular ArticleSelf-assembly of amphiphilic block copolymers induces polymeric micelles which have attracted significant attention as potential delivery vehicles for genes, 1,2) imaging agents, 3) and anticancer drugs. 4,5) Normally, these polymeric micelles are characterized by unique core-shell architectures which have nanoscale size (10 to 100 nm diameter) and a fairly narrow size distribution. These unique structures endow the formed assemblies with good loading capacity and releasing efficiency. However, the incorporation of metal ions is not successful by amphiphilic block copolymer aggregates, due to the poor compatibility between the hydrophobic cores and metal ions. Recently, double-hydrophilic block copolymers (DHBCs) were developed, which contain ionic and nonionic water-soluble segments (block ionomers), as novel functional materials for pharmaceutical applications. 6) Among the DHBCs, poly(ethylene glycol)-block-poly(acrylic acid), PEG-b-PAA, is one of the most popular polymers and has been employed to prepare the polymeric micelles by the electrostatic complexation with positive-charged functional species. The PAA core of the micelles is a loading space that accommodates various positive-charged therapeutic or diagnostic molecules. The hydrophilic PEG shell is a brush-like corona that stabilizes the nanostructure in aqueous dispersion. Meanwhile, PEG is biocompatible for these physicochemical properties such as hydrophilicity, anticoagulant, solubility, non-immunogenecity, and able to resist protein adsorption, thus, it has been approved by food and drug administration (FDA) for clinical using. 7) PEG shell on the surface of micelles increases the residence time of circulation in blood, preventing interactions with serum proteins and minimizes the detection by the immune system. 8) Therefore, it is frequently used as the hydrophilic block of amphiphilic block copolymers to create some polymersomes.Chemotherapy has become an integral component of cancer treatment for most cancers. The metal anticancer drugs occupy the most promising space in the field of pharmaceutical chemotherapy. In 1991, Waalkes et al. found cadmium injection suppressed spontaneous liver tumor proliferation on the research for initiate or promote tumors on B6C3F1 mouse liver. 9) This result indicated cadmium might be used for tumor treatment. From then on, more and more attention has been paid about the effect of cadmium on antitumor. Our team has been some studies on effects of cadmium on human carcinoma cell. Likewise, our results showed that cadmium could significantly inhibit cellular proliferation, induce DNA damage, cause cell cycle arrest and apoptosis in vitro, and suppresse the growth of hepatocellular carcinoma cells xenografts in vivo. 10,11) Cadmium can induce metallothionein (MT), a non-specific protective protein which could combine with cadmium to reduce toxicity. Furthermore, due to the lower MT expression in hepatoma tissues, compared with normal liver tissue, free cadmium would preferably accumulate in hepatoma...